SING GEORGE L has filed 39 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 1962 shares of REGENERON PHARMACEUTICALS, INC. ($REGN) on January 02, 2026.
Activity breakdown: 0 open-market purchases and 8 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | A | Non-Qualified Stock Option (right to buy) | 1962 | $0.00 | 1,962.0000 | 137,600,000 | 9999.99% | 0.00% |
| Jan. 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | A | Common Stock | 155 | $0.00 | 33,157.0000 | 137,600,000 | 0.47% | 0.00% |
| Dec. 30, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Non-Qualified Stock Option (right to buy) | 9212 | $0.00 | 0.0000 | 136,200,000 | 100.00% | 0.01% |
| Dec. 30, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | F | Common Stock | 6188 | $774.03 | 33,002.0000 | 136,200,000 | 15.79% | 0.00% |
| Dec. 30, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Common Stock | 9212 | $520.01 | 39,190.0000 | 136,200,000 | 30.73% | 0.01% |
| Dec. 31, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Common Stock | 3338 | $413.33 | 31,760.0000 | 135,300,000 | 11.74% | 0.00% |
| Dec. 31, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | F | Common Stock | 1948 | $708.19 | 29,812.0000 | 135,300,000 | 6.13% | 0.00% |
| Jan. 2, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | A | Common Stock | 166 | $0.00 | 29,978.0000 | 136,000,000 | 0.56% | 0.00% |
| Dec. 31, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Non-Qualified Stock Option (right to buy) | 3338 | $0.00 | 0.0000 | 135,300,000 | 100.00% | 0.00% |
| Jan. 2, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | A | Non-Qualified Stock Option (right to buy) | 1958 | $0.00 | 1,958.0000 | 136,000,000 | 9999.99% | 0.00% |
| Sept. 4, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | G | Common Stock | 1200 | $0.00 | 28,422.0000 | 134,800,000 | 4.05% | 0.00% |
| May 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Common Stock | 2000 | $413.33 | 30,499.0000 | 134,199,999 | 7.02% | 0.00% |
| May 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | F | Common Stock | 877 | $942.53 | 29,622.0000 | 134,199,999 | 2.88% | 0.00% |
| May 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Non-Qualified Stock Option (right to buy) | 2000 | $0.00 | 3,338.0000 | 134,199,999 | 37.47% | 0.00% |
| Feb. 26, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | S | Common Stock | 500 | $990.00 | 28,499.0000 | 133,100,000 | 1.72% | 0.00% |
| Feb. 26, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Common Stock | 500 | $413.33 | 28,999.0000 | 133,100,000 | 1.75% | 0.00% |
| Feb. 26, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | S | Common Stock | 500 | $995.00 | 28,499.0000 | 133,100,000 | 1.72% | 0.00% |
| Feb. 26, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Non-Qualified Stock Option (right to buy) | 1000 | $0.00 | 5,338.0000 | 133,100,000 | 15.78% | 0.00% |
| Feb. 26, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Common Stock | 500 | $413.33 | 28,999.0000 | 133,100,000 | 1.75% | 0.00% |
| Feb. 22, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | S | Common Stock | 1000 | $960.00 | 28,499.0000 | 133,100,000 | 3.39% | 0.00% |
| Feb. 23, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Common Stock | 500 | $413.33 | 28,999.0000 | 133,100,000 | 1.75% | 0.00% |
| Feb. 23, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | S | Common Stock | 500 | $985.00 | 28,499.0000 | 133,100,000 | 1.72% | 0.00% |
| Feb. 22, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Non-Qualified Stock Option (right to buy) | 3000 | $0.00 | 6,838.0000 | 133,100,000 | 30.49% | 0.00% |
| Feb. 23, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Non-Qualified Stock Option (right to buy) | 500 | $0.00 | 6,338.0000 | 133,100,000 | 7.31% | 0.00% |
| Feb. 22, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Common Stock | 1000 | $413.33 | 29,499.0000 | 133,100,000 | 3.51% | 0.00% |
| Feb. 22, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | S | Common Stock | 1000 | $965.00 | 28,499.0000 | 133,100,000 | 3.39% | 0.00% |
| Feb. 22, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Common Stock | 1000 | $413.33 | 29,499.0000 | 133,100,000 | 3.51% | 0.00% |
| Feb. 22, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | S | Common Stock | 1000 | $970.00 | 28,499.0000 | 133,100,000 | 3.39% | 0.00% |
| Feb. 22, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Common Stock | 1000 | $413.33 | 29,499.0000 | 133,100,000 | 3.51% | 0.00% |
| Feb. 8, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Non-Qualified Stock Option (right to buy) | 500 | $0.00 | 10,338.0000 | 133,100,000 | 4.61% | 0.00% |
| Feb. 8, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | S | Common Stock | 500 | $945.00 | 28,499.0000 | 133,100,000 | 1.72% | 0.00% |
| Feb. 9, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Common Stock | 500 | $413.33 | 28,999.0000 | 133,100,000 | 1.75% | 0.00% |
| Feb. 9, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | S | Common Stock | 500 | $955.00 | 28,499.0000 | 133,100,000 | 1.72% | 0.00% |
| Feb. 9, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Non-Qualified Stock Option (right to buy) | 500 | $0.00 | 9,838.0000 | 133,100,000 | 4.84% | 0.00% |
| Feb. 8, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | M | Common Stock | 500 | $413.33 | 28,999.0000 | 133,100,000 | 1.75% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | A | Common Stock | 135 | $0.00 | 28,499.0000 | 133,100,000 | 0.48% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | A | Non-Qualified Stock Option (right to buy) | 1607 | $0.00 | 1,607.0000 | 133,100,000 | 9999.99% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | A | Common Stock | 165 | $0.00 | 28,364.0000 | 130,400,000 | 0.59% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | SING GEORGE L | Director | A | Non-Qualified Stock Option (right to buy) | 1929 | $0.00 | 1,929.0000 | 130,400,000 | 9999.99% | 0.00% |